Scholarly article on topic 'Sensitivity and Specificity of the Toe-Brachial Index for Detecting Peripheral Arterial Disease: Initial Findings'

Sensitivity and Specificity of the Toe-Brachial Index for Detecting Peripheral Arterial Disease: Initial Findings Academic research paper on "Clinical medicine"

0
0
Share paper
Academic journal
Journal of Ultrasound in Medicine
OECD Field of science
Keywords
{""}

Academic research paper on topic "Sensitivity and Specificity of the Toe-Brachial Index for Detecting Peripheral Arterial Disease: Initial Findings"

ORIGINAL RESEARCH

Sensitivity and Specificity of the Toe-Brachial Index for Detecting Peripheral Arterial Disease

Initial Findings

Peta Tehan, B Health Sc (Pod) G Cert Wound Care, Alan Bray, MBBS, FRACS (Vascular Surgery), MD, DDU, Ruth Keech, Grad Dip Ultrasonography, DMU (Vascular), Richard Rounsley, Dip Health Sc (Pathology), B Med Sc, DMU (Vascular), Angela Carruthers, B Health Sc, RN, Vivienne Helaine Chuter, B Pod (Hons), PhD

Objectives—The toe-brachial index (TBI) is an alternative to the ankle-brachial index (ABI) in screening for peripheral arterial disease (PAD); however, there is limited evidence comparing their diagnostic accuracy. This study compared the diagnostic accuracy of the ABI and TBI in a population at risk of PAD.

Methods—The sensitivity and specificity ofthe ABI and TBI were determined by color duplex sonography. Receiver operating characteristic (ROC) analysis was performed.

Results—A total of119 participants were recruited (75 male and 44 female). The sensitivity for PAD was highest for the TBI (71%; ABI, 45%), and the specificity was highest for the ABI (93%; TBI, 78%). Receiver operating characteristic analysis indicated that the TBI (ROC area, 0.77; P = .0001) had greater clinical efficacy for diagnosis of PAD than the ABI (ROC area, 0.65; P = .005).

Conclusions—In specific populations, the TBI may have greater clinical efficacy than the ABI for diagnosis of PAD.

Key Words—ankle-brachial index; peripheral arterial disease; sensitivity; specificity; toe-brachial index; vascular ultrasound

Received October 1, 2014, from the School of Health Sciences, Faculty of Health, University of Newcastle, Ourimbah, New South Wales, Australia (P.T., V.H.C.); and Vascular Health Care, Gateshead, New South Wales, Australia (A.B., R.K., R.R., A.C.). Revision requested November 5,2014. Revised manuscript accepted for publication December 23,2014.

This project was funded by a University of Newcastle new staff grant and early career researcher grant.

Address correspondence to Peta Tehan, B Health Sc (Pod) G Cert Wound Care, School of Health Sciences, University of Newcastle, PO Box 127, Ourimbah NSW2258, Australia.

E-mail: peta.craike@newcastle.edu.au

Abbreviations

ABI, ankle-brachial index; CI, confidence interval; ICC, intraclass correlation coefficient; PAD, peripheral arterial disease; ROC, receiver operating characteristic; TBI, toe-brachial index

doi:10.7863/ultra.15.14.09071

Peripheral arterial disease (PAD) involves progressive stenosis and, potentially, occlusion of arterial beds supplying the lower extremity through the development ofatherosclerosis. The risk ofPAD increases with age, affecting 21% ofthose older than 65 years, and in the presence of risk factors such as smoking, diabetes, dyslipidemia, and hypertension.1^ As many people with PAD are asymptomatic, the condition is highly under-recognized3 and if untreated can ultimately lead to the development ofwounds, gangrene, and amputation.4 The presence ofPAD is also an indicator ofsystemic arterial disease and is associated with an increased risk of a cardiovascular event5 and associated mortality.6

Traditionally, the ankle-brachial index (ABI) has been used as a noninvasive method for assessing peripheral vascular status in patients at risk of PAD. An ABI is calculated by taking the higher of the systolic pressure of the dorsalis pedis or posterior tibial artery and dividing it by the highest systolic brachial pressure.7 An ABI of greater than 1.0 is considered normal,7 with a ratio of less than 0.90 considered diagnostic for PAD.8

©2015 by the American Institute of Ultrasound in Medicine J Ultrasound Med 2015; 34:1737-1743 0278-4297 www.aium.org

The ABI is a highly sensitive and specific screening tool for PAD.8'9 The relative simplicity of application and low cost make the ABI an easily accessible assessment tool for many clinicians. However, recent research suggests that the diagnostic accuracy of the ABI is reduced in specific populations. Decreased sensitivity and specificity ofthe ABI for the presence of PAD have been demonstrated in the elderly and in the presence of renal disease or diabetes.10'11 It is widely recognized that higher rates of medial arterial calcification in these populations leads to stiffening of the arterial wall, preventing full compression of the lower extremity arteries, inflating the ABI value, and reducing the clinical efficacy ofthe test.10,12 An elevated ABI (>1.4), is generally accepted to be indicative of medial arterial calcification.8 However, further complicating lower extremity vascular testing in these patients, the presence of medial arterial calcification is also associated with substantial lower extremity atherosclerosis.13 The combination of these two conditions may result in a normal ABI in the presence of substantial PAD due to partial loss of compressibility of the artery, leading to undiagnosed PAD. Additionally, more distal anatomic distribution of atherosclerotic lesions occurring in both people with diabetes and those of advanced age2 further affects the ABI, with an inability to detect stenosis of arteries at the level of, or distal to, the ankle by ankle pressure measurements.12

Alternative methods of noninvasive vascular assessment may be performed using small vessel-testing methods such as the toe-brachial index (TBI). The TBI is a ratio of the systolic toe pressure divided by the highest systolic brachial pressure.7 Normal values for the TBI are less than those for the ABI, with 0.7 and greater considered normal.14-16 The TBI has been shown to be an accurate indicator of PAD in specific populations who are prone to medial calcification, including those with diabetes-related PAD, sensorimotor neuropathy,10 and patients undergoing hemodialysis for end-stage renal failure.11^7 The TBI is by no means a new assessment method; however, its use remains limited, particularly in the vascular laboratory.

Despite the potentially wide applicability of the TBI as a test for PAD, evidence evaluating its diagnostic accuracy is limited. There is also a lack of comparative data assessing the relative diagnostic accuracy of the TBI and ABI for the presence of PAD using diagnostic imaging as the reference standard. The aim ofthis study was to examine the sensitivity and specificity of the TBI and the comparative diagnostic accuracy of the TBI versus the ABI for detecting PAD in a population of patients at risk of PAD.

Materials and Methods

This study was undertaken at a private vascular clinic in Lake Macquarie, New South Wales, Australia. Ethical approval was obtained from the University of Newcastle Human Research Ethics Committee. All participants provided written informed consent before participation.

Over 28 months (August 2011-December 2013), participants were recruited on a volunteer basis from a private vascular clinic and a podiatry service in Newcastle. Inclusion criteria were set in accordance with current guidelines for lower extremity vascular screening18: participants older than 65 years or older than 50 years with a history of diabetes, current smoking, exertional leg pain, or nonhealing wounds. Exclusion criteria were contraindications to ankle, toe, and brachial pressure measurements, including active hallux or leg ulceration preventing cuff placement, history of deep venous thrombosis, lymphedema, and previous bilateral mastectomy or vasospastic disorders.

All participants attended a single testing session at the vascular clinic with 1 of 3 sonographers. During the testing session, ABI and TBI measurements, color duplex sonography, and neurologic testing were performed on the right leg. Color duplex sonography was chosen, as it has been demonstrated to be a valid imaging technique for noninvasive vascular diagnostic testing.^19 The right limb only was used to comply with the assumption of independence ofdata in statistical testing.20 The medical history was obtained from each participant. Participants were asked to avoid alcohol, smoking, exercise, and caffeine 1 hour before the testing session to avoid influencing pressure measurements.21 Participants were placed in a supine position and rested for at least 10 minutes before pressure measurements. A subset of 10 participants randomly selected returned within 1 week of the initial testing session. At the second testing session, all tests (vascular and neurologic) were repeated by a different clinician blinded to the results of the initial test to establish intertester reliability.

Color duplex sonography was performed with either a CX-50 ultrasound system (Philips Healthcare, Best, the Netherlands) or a LOGIQI system (GE Healthcare, Little Chalfont, England). All ankle and brachial pressures and continuous wave Doppler tracings of pedal arteries were taken with a Parks 1050c Vascular Minilab (Parks Medical Electronics, Inc, Aloha, OR) equipped with 8.2MHz continuous wave Doppler, a Parks standard 10-cm inflatable cuff, and an ERKA switch blood pressure gauge (ERKA Kallmeyer Medizintechnik GmbH & Co. KG, Bad Tolz, Germany). Toe pressures were obtained with

a photoplythsmograph probe, a Hokanson toe pressure cuff (1.6, 1.9, or 2.5 cm; D. E. Hokanson, Inc, Bellvue, WA), and an ERKA switch blood pressure gauge. The size of the cuff used was in accordance with current guidelines for cuff size.7

Room temperature was monitored with a thermometer and was maintained between 23°C and 25°C.22 Bilateral brachial systolic pressures were obtained in all participants with a Parks continuous wave Doppler system and a handheld sphygmomanometer. Ankle systolic pressures of the right leg only were taken by placing the brachial pressure cuff around the lower leg, proximal to the medial and lateral malleoli. Both dorsalis pedis and posterior tibial artery pressures were recorded, with the higher of the two being used for calculation of the ABI. Toe systolic pressures were obtained by placing a photoplythsmograph probe directly on the distal pulp of the right great toe, affixed with adhesive tape. Once a clear signal was obtained, a toe cuffwas placed immediately proximal to the photoplythsmograph probe. If the great toe was too large for the toe cuff, the second toe was used. The cuff was then inflated to 20 mm Hg above the last visual photoplythsmograph signal. The cuff was then slowly deflated, and the pressure reading was recorded when a consistent waveform returned. The TBI was calculated by dividing the toe pressure by the highest brachial pressure.

Color duplex sonography was performed after pressure measurements, from the abdominal aorta to the distal ankle on the right side as the reference standard. For calculations relating to diagnostic accuracy, the presence ofPAD was defined as 1 or more arteries with greater than 50% stenosis.23,M Distal disease was defined as disease distal to and including the proximal popliteal artery, and proximal disease was defined as disease from the common iliac artery to the distal superficial femoral artery. The sensitivity, specificity, diagnostic accuracy, and positive predictive value of the ABI and TBI for the presence of PAD were calculated by using the standard cutoff scores for an abnormal ABI of0.90 or less and greater than 1.4, consistent with current screening guidelines,7 and the suggested cutoff score for the TBI of less than 0.70.9,25 Ankle pressures exceeding 200 mm Hg were considered incompressible.7 Receiver operating characteristic (ROC) analysis was performed for the ABI and TBI and was calculated with SPSS version 19 statistical software (IBM Corporation, Armonk, NY). Standard deviations were derived for all means, sensitivities, specificities, and positive and negative predictive values. Calculations of diagnostic accuracy were performed with Microsoft Excel (Microsoft Corporation, Redmond, WA).

Intertester reliability of color duplex sonography was calculated by using the presence or absence of PAD as a dichotomous variable and an unweighted Cohen k statistic. Intraclass correlation coefficients (ICCs) with 95% confidence intervals (CIs) were calculated to determine the level of agreement between test and retest for the ABI and TBI. All ICC values for intertester reliability were interpreted according to cutoffs suggested by Fleiss.26 Interpretation of the Cohen k statistic was performed by the method proposed by Landis and Koch.27 All reliability analyses were conducted with SPSS version 19 software.

Results

A total of 120 participants were recruited. One participant was excluded, as the color duplex sonographic scan was performed on a different day from the remainder ofthe vascular examination. Participant characteristics are included in Table 1.

The mean ABI was 1.13 (SD, 0.23). The mean fell within the normal range for an ABI measurement. The ABI results ranged from 0.34 to 2.0, which indicated that the participants' peripheral arterial status included both those with substantial PAD and substantial medial arterial calcification. The ABI was more likely to fail to diagnose the presence of PAD. Receiver operating characteristic analysis showed that the ROC area for an ABI set at less than 0.9 or greater than 1.4 for detecting PAD was only 0.65 (95% CI, 0.54-0.77; Figure 1). This result indicates that the ABI was a poor test in this population.28 The sensitivity and negative predictive value of 45% and 69%, respectively, for the ABI reflect an increased risk of failure to diagnose existing disease (Table 2). However, the specificity (93%) and

Table 1. Participant Characteristics

Characteristic Value

Total participants, n 119

Male, n (%) 75 (63.02)

Female, n (%) 44 (36.97)

Age range, y 53-92

Diabetes, n (%) 73 ( 61.34)

Mean age (SD), y 73.1 ( 7.2)

Incompressible ankle pressure, n (%) 16 (13.44)

Distal PAD, n (%) 37 (31.09)

Proximal PAD, n (%) 7 (5.88)

Distal and proximal PAD, n (%) 7 (5.88)

PAD, n (%) 51(42.85)

Proximal occlusions, n (%) 1 (0.84)

Distal occlusions, n (%) 40 (33.61)

positive predictive value (82%) were high, indicating that the ABI is relatively unlikely to falsely diagnose PAD.

The mean TBI was 0.71 (SD, 0.21) which was within the normal range. The ROC area was 0.77 (95% CI, 0.69-0.87), indicating that the TBI was a fair test in this population (Figure 1). The sensitivity of the TBI for detecting PAD was 71%, indicating that the TBI was quite likely to accurately detect PAD in this population (Table 2). The specificity was 79%, which, whereas lower than the ABI result, suggests that the TBI is relatively unlikely to falsely detect PAD.

The intertester reliability of the color duplex sonographic scans between the 3 sonographers was high (k = 0.78; P < .01).27 The ICCs showed good test-retest reliability ofthe toe pressures (ICC, 0.80; 95% CI, 0.39-0.95) and moderate reliability of the brachial pressures (ICC, 0.66, 95% CI, 0.09-0.90) and ankle pressures (ICC, 0.62; 95% CI, 0.03-0.89).29

Discussion

The results of this study indicate that overall the TBI has much higher sensitivity (71%) for the presence of PAD than the ABI (45%). However, the ABI had slightly higher specificity (93%) than the TBI (79%). The negative predictive value of the ABI (69%) together with poor ROC analysis (0.65) has significant clinical implications, leaving approximately one-third ofparticipants falsely undiagnosed.

Previous research studies have reported a range of results regarding the sensitivity ofthe ABI, depending on the cohort of participants studied. In healthy individuals, the ABI has been shown to be highly sensitive (95%)30-33; however, in patients with diabetes or renal disease, the sensitivity ofthe ABI has been shown to be considerably lower (29.9%-53%).10,11 The population in this study met current criteria for lower extremity vascular screening and consisted ofan older group with a large number ofpeople with diabetes. The findings of our study suggest that there may be a high prevalence of concurrent medial arterial calcification and

Table 2. Diagnostic Results

Characteristic ABI TBI

Mean (SD) 1.13 (0.23) 0.71 (0.21)

Sensitivity (95% CI), % 45 (32-59) 71 (57-81)

Specificity (95% CI), % 93 (84-97) 79 (67-87)

Positive predictive value (95% CI), % 82(63-93) 72 (57-83)

Negative predictive value (95% CI), % 69 (58-78) 77 (65-86)

ROC area (P) 0.65 (.005) 0.77 (.0001)

PAD within the general population, requiring peripheral vascular screening. This prevalence is expected, as this population is older and at higher risk ofcomorbidities such as diabetes, which are both associated with the development of medial arterial calcification. Although medial arterial calcification is known to affect the accuracy of the ABI in people with diabetes, renal disease, and older age, the prevalence ofclinical and subclinical medial arterial calcification within the general population remains controversial.

Medial arterial calcification has been estimated to affect approximately 13.3% of men and 6.9% of women in a population at risk of PAD.34 However, cutoff points for diagnosis of medial arterial calcification by the ABI have been questioned. Further complicating matters, the presence of subclinical medial arterial calcification has been proposed, which goes undetected by the ABI.4 It is therefore difficult to determine the extent to which the accuracy of the ABI may be affected and the efficacy of using the measurement as a screening tool. Current recommendations suggest that a toe pressure be used only in the presence of an ABI elevated to greater than 1.40; however, these recommendations do not address the presence of PAD coexisting with medial arterial calcification, which may reduce the ABI to within a normal range.12,35-37 This study supports previous findings indicating that the ABI has decreasing levels of sensitivity in a population at risk of PAD and concurrent medial arterial calcification. Conversely, the specificity of the ABI (93%) in this study was higher than that ofthe TBI (79%). Previous studies in different populations have shown that the ABI had differ-

Figure 1. Receiver operating characteristic analysis: TBI versus ABI. Diagonal segments are produced by ties.

ooH-1-1-1-1-

0.0 0.2 0.4 0.6 0.8 1.0

1 - Specificity

ing specificity rates (88%-100%)10,n; however, this study included a mixed population with a larger sample size, and participants rested for 10 minutes, which has been shown to be the ideal rest time for ankle pressures.38 This factor may have resulted in higher specificity rates.

Previous research in small cohorts of people with diabetes has shown that the TBI had superior sensitivity for the presence of PAD compared to the ABI.10 In this study, the TBI also had superior sensitivity and ROC results compared to the ABI. Although the specificity of the TBI was lower than that of the ABI, the TBI still faired better overall, showing a more significant result with ROC analysis. This finding suggests that the TBI has a wider applicability to a broader population at risk of PAD than previously believed.

In this study, 61% of the participants had diabetes, and the average age was older than previously reported. As both advanced age and diabetes are associated with more distally distributed atherosclerotic lesions,2 these participants had higher rates of distally located stenoses. Our finding of increased sensitivity of the TBI for PAD in our sample is congruent with previous suggestions that the TBI has high sensitivity for more distally distributed disease and should therefore be a test of choice in populations at risk of such disease patterns. However it is important to note that in this study, a photoplythsmograph probe was used to measure the TBI. There are other methods of obtaining toe pressures, including strain gauge plethysmography, oscil-lometric plethysmography, and laser Doppler imaging; therefore, our study applies only to the photoplythsmo-graph method.

In addition to being highly sensitive, our results also suggest that the TBI had higher specificity (79%) than previously reported in small groups of people with diabetes (61%-65%).10 However, this difference may be due to the effect of diabetes on microcirculation and impairment of vasodilatory capacity, which would remain undetected by large vessel-screening methods such as the ABI and color duplex sonography.22 The presence of microvascular disease that drops the TBI without coexistent PAD would reduce the specificity of the test for PAD. Conversely, in studies examining people with chronic renal failure, the specificity of both the TBI and the ABI has been shown to be up to 100%, potentially due to the high rates of medial arterial calcification in this population without the presence of peripheral microvascular disease.11

To our knowledge, a study assessing the sensitivity and specificity of the TBI across a mixed population at risk of PAD has not been reported previously. However, the findings of this study need to be considered carefully

because ofsome potential limitations. Although a valid form of noninvasive vascular assessment, color duplex sonography is heavily dependent on operator skill, and whereas an intertester reliability study was performed and shown to be adequate, the results are nevertheless subjective and dependant on clinician skill and experience. The intertester reliability testing for color duplex sonography was limited to 10 participants due to financial restraints and may not have been statistically robust; however, it had a similar participant number as another study of diagnostic accuracy using color duplex sonography as a reference standard.10 Our convenience sample consisted of a large proportion of people with diabetes and an older mean age; however, this factor reflects the sample population, who were attending a podiatry and vascular clinic and were at risk ofPAD. People older than 75 have a higher prevalence ofPAD.3 People with diabetes are at increased risk ofPAD, with disease occurring earlier and more aggressively, with a more distal distribution frequently reported.39 The results of this study therefore reflect a population at substantial risk ofPAD with more distally located stenoses.

In conclusion, this study demonstrated that the TBI had greater sensitivity than the ABI in participants at risk of PAD. The specificity of the TBI was lower than that of the ABI but higher than previously reported. These results suggest that the TBI may be a more clinically effective form of vascular assessment in this population. Further research in larger cohorts is required to further elucidate the sensitivity and specificity ofthe TBI in broad populations at risk ofPAD.

References

1. Diehm C, Allenberg JR, Pittrow D, et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral arterial disease. Circulation 2009; 120:2053-2061.

2. Diehm N, Shang A, Silvestro A, et al. Association of cardiovascular risk factors with pattern oflower limb atherosclerosis in 2659 patients undergoing angioplasty. Eur J Vasc Endovasc Surg 2006; 31:59-63.

3. Criqui MH. Peripheral arterial disease: epidemiological aspects. Vasc Med 2001; 6(suppl):3-7.

4. Belch JJ, Topol EJ, Agnelli G, et al. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 2003; 163:884-892.

5. Weitz JI, Byrne J, Clagett GP, et al. Diagnosis and treatment of chronic arterial insufficiency ofthe lower extremities: a critical review. Circulation

1996; 94:3026-3049.

6. Dieter RS, Chu WW, Pacanowski JP Jr, McBride PE, Tanke TE. The significance oflower extremity peripheral arterial disease. Clin Cardiol 2002; 25:3-10.

7. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA Guidelines for the Management ofPatients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society oflnterventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management ofpatients with peripheral arterial disease)—summary ofrecommendations. J Vasc Interv Radiol 2006; 17:1383-1397.

8. Norgren L Hiatt WR, DormandyJA, et al. Inter-society consensus for the management ofperipheral arterial disease (TASC II). J Vasc Surg 2007; 33(suppl):S1-S75.

9. Rooke TW, Hirsch AT, Misra S, et al. 2011 ACCF/AHA Focused Update ofthe Guideline for the Management ofPatients With Peripheral Artery Disease (updating the 2005 guideline): a report ofthe American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2011; 58:2020-2045.

10. Williams DT, Harding KG, Price P. An evaluation ofthe efficacy ofmeth-ods used in screening for lower-limb arterial disease in diabetes. Diabetes Care 2005; 28:2206-2210.

11. Okamoto K, Oka M, Maesato K, et al. Peripheral arterial occlusive disease is more prevalent in patients with hemodialysis: comparison with the findings of multidetector-row computed tomography. Am J Kidney Dis 2006; 48:269-276.

12. Aerden D, Massaad D, von Kemp K, et al. The ankle-brachial index and the diabetic foot: a troublesome marriage. Ann Vasc Surg2011; 25:770777.

13. Aboyans V, Ho E, DenenbergJO, Ho LA, Natarajan L, Criqui MH. The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects. J Vasc Surg2008;

48:1197-1203.

14. Carter SA, Lezack JD. Digital systolic pressures in the lower limb in arterial disease. Circulation 1971; 43:905-914.

15. Ramsey DE, Manke DA, Sumner DS. Toe blood pressure: a valuable adjunct to ankle pressure measurement for assessing peripheral arterial disease. J Cardiovasc Surg 1983; 24:43-48.

16. Brooks B, Dean R, Patel S, Wu B, Molyneaux L, Yue DK TBI or not TBI: that is the question. Is it better to measure toe pressure than ankle pressure in diabetic patients? Diabet Med 2001; 18:528-532.

17. Ohtake T, Oka M, Ikee R, et al. Impact oflower limbs' arterial calcification on the prevalence and severity ofPAD in patients on hemodialysis. J Vasc Surg 2011; 53:676-683.

18. Rooke TW, Hirsch AT, Misra S, et al. 2011 ACCF/AHA Focused Update ofthe Guideline for the Management ofPatients With Peripheral artery Disease (updating the 2005 guideline): a report ofthe American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Inter-ventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery. Catheter Cardiovasc Interv 2012; 79:501-531.

19. Collins R, Burch J, Cranny G, et al. Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment ofsymptomatic, lower limb peripheral arterial disease: systematic review. BMJ 2007; 334:1257.

20. Menz HB. Analysis ofpaired data in physical therapy research: time to stop double-dipping? J Orthop SportsPhys Ther 2005; 35:477-478.

21. Campbell NR, Chockalingham A, Fodor JG, McKay DW. Accurate, reproducible measurement ofblood pressure. CMAJ1990; 143:19-24.

22. Sawka AM, Carter SA. Effect oftemperature on digital systolic pressures in lower limb in arterial disease. Circulation 1992; 85:1097-1101.

23. Sacks D, Robinson ML, Marinelli DL, Perlmutter GS. Peripheral arterial Doppler ultrasonography: diagnostic criteria. J Ultrasound Med 1992; 11:95-103.

24. Koelemay MJW, den Hartog D, Prins MH, Kromhout JG, Legemate DA, Jacobs MJHM. Diagnosis ofarterial disease ofthe lower extremities with duplex ultrasonography. Br J Surg 1996; 83:404-409.

25. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the Management ofPatients with Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): a collaborative report from the American Association for Vascular Surgery/Society forVascular Surgery, Society for CardiovascularAngiog-raphy and Interventions, Society forVascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management ofPatients With Peripheral Arterial Disease), endorsed by the American Association ofCardiovascular and Pulmonary Rehabilitation, National Heart, Lung, and Blood Institute, Society forVascular Nursing, TransAtlantic Inter-Society Consensus, and Vascular Disease Foundation. Circulation 2006; 113:e463-e654.

26. Fleiss J. Reliability of Measurement. 1st ed. New York, NY: John Wiley & Sons; 1986.

27. Landis JR, Koch GG. The measurement ofobserver agreement for categorical data. Biometrics 1977; 33:159-174.

28. Akobeng AK Understanding diagnostic tests, 3: receiver operating characteristic curves. Acta Paediatr 2007; 96:644-647.

29. Portney L, Watkins M. Foundations of Clinical Research: Applications to Practice. 3rd ed. Cranbury, NJ: Pearson Education; 2009.

30. Hiatt WR, Jones DN. The role ofhemodynamics and duplex ultrasound in the diagnosis of peripheral arterial disease. Curr Opin Cardiol 1992; 7:805-810.

31. Jelinek H, Austin M. The ankle-brachial index in clinical decision making. Foot 2006; 16:153-157.

32. Bhasin N, Scott DJ. Ankle brachial pressure index: identifying cardiovascular risk and improving diagnostic accuracy. J R Soc Med 2007; 100:4-5.

33. Allen J, Overbeck K, Nath AF, Murray A, Stansby G. A prospective comparison ofbilateral photoplethysmographyversus the ankle-brachial pressure index for detecting and quantifying lower limb peripheral arterial disease. J Vasc Surg 2008; 47:794-802.

34. Faglia E. Characteristics ofperipheral arterial disease and its relevance to the diabetic population. Int J Low Extrem Wounds 2011; 10:152-166.

35. Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laakso M. Medial artery calcification: a neglected harbinger ofcardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb VascBiol 1996; 16:978-983.

36. Neubauer B. A quantitative study of peripheral arterial calcification and glucose tolerance in elderly diabetics and non-diabetics. Diabetologia 1971;

7:409-413.

37. Young MJ, Adams JE, Anderson GF, Boulton AJM, Cavanagh PR. Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects. Diabetologia 1993; 36:615-621.

38. Sadler S, Hawke F, Chuter V. Effect of pre-rest test duration on toe and ankle systolic pressure measurements [abstract]. J Foot Ankle Res 2013; 6(suppl 1):13.

39. Norman PE, EikelboomJW, Hankey GJ. Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications.

MedJ Aust 2004; 181:150-154.